Bharat Biotech's indigenous COVID-19 vaccine 'COVAXIN' gets approval for phase I & II human clinical trials

Credit: DNA- Published 3 days ago
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad.

Video credit: KTNV Channel 13 Las Vegas
Published 2 days ago -  02:29
Race to create a vaccine
The race to create a coronavirus vaccine is picking up. 17 possible vaccines are in clinical evaluation, with one already in wide-scale human trials.

You are here

Related videos from verified sources

China Approves COVID-19 Vaccine For Human Trials In Military Personnel 00:30
Credit: Wochit - Published 2 days ago 


Covid-19 vaccine: India ready for human trials of indigenously developed Covaxin | Oneindia News 01:17
Credit: Oneindia - Published 2 days ago 


Wisconsin researchers in race for coronavirus vaccine 01:23
Credit: WISN - Published 2 weeks ago 


Related news from verified sources

Indiaโ€™s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
3 days ago • IndiaTimes